Reproductive Biology and Endocrinology Open Access Rats with Steroid-induced Polycystic Ovaries Develop Hypertension and Increased Sympathetic Nervous System Activity

Background: Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder associated with ovulatory dysfunction, abdominal obesity, hyperandrogenism, hypertension, and insulin resistance.

[1]  E. Stener-Victorin,et al.  Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries , 2005, Autonomic Neuroscience.

[2]  D. Healy,et al.  Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[3]  R. Hart,et al.  Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[4]  G. Johannsson,et al.  Low birth size and final height predict high sympathetic nerve activity in adulthood , 2004, Journal of hypertension.

[5]  R. Legro,et al.  Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls , 2004, Obstetrical & gynecological survey.

[6]  G. Nagy,et al.  Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. , 2003, Molecular endocrinology.

[7]  R. Cífková,et al.  Cardiovascular risk factors in young Czech females with polycystic ovary syndrome. , 2003, Human reproduction.

[8]  S. Oparil,et al.  &agr;2A-Adrenergic Receptors Mediate Sympathoinhibitory Responses to Atrial Natriuretic Peptide in the Mouse Anterior Hypothalamic Nucleus , 2003, Hypertension.

[9]  A. Mayerhofer,et al.  Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release , 2002, Microscopy research and technique.

[10]  A. Goodchild,et al.  Catecholamine-Related Gene Expression Correlates With Blood Pressures in SHR , 2002, Hypertension.

[11]  W. Kannel.  The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. , 2002, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

[12]  P. Blankestijn,et al.  Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. , 2001, Journal of the American Society of Nephrology : JASN.

[13]  F. de Zegher,et al.  Polycystic ovary syndrome after precocious pubarche: ontogeny of the low‐birthweight effect , 2001, Clinical endocrinology.

[14]  E. Stener-Victorin,et al.  Effects of electro-acupuncture on corticotropin-releasing factor in rats with experimentally-induced polycystic ovaries , 2001, Neuropeptides.

[15]  K. Spanel‐Borowski,et al.  Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. , 2001, Fertility and sterility.

[16]  B. Folkow.  Mental Stress and its Importance for Cardiovascular Disorders; Physiological Aspects, "From-Mice-to-Man" , 2001, Scandinavian cardiovascular journal : SCJ.

[17]  P. Wellman.  Norepinephrine and the control of food intake. , 2000, Nutrition.

[18]  G. Chrousos.  The role of stress and the hypothalamic–pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes , 2000, International Journal of Obesity.

[19]  S. Ojeda,et al.  An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. , 2000, Endocrinology.

[20]  A. Galecki,et al.  Sympathetic nervous system activity and α-adrenergic responsiveness in older hypertensive humans. , 1999, American journal of physiology. Endocrinology and metabolism.

[21]  G. Smith,et al.  CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. , 1999, Endocrinology.

[22]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[23]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[24]  H. Lara,et al.  Hypothalamic changes in norepinephrine release in rats with estradiol valerate-induced polycystic ovaries. , 1995, Biology of reproduction.

[25]  R. Heine,et al.  Induction of insulin resistance by androgens and estrogens. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  A. Kitabchi,et al.  Enhanced adrenocortical activity as a contributing factor to diabetes in hyperandrogenic women. , 1994, Metabolism: clinical and experimental.

[27]  S. Johansson,et al.  Hemostatic and metabolic variables in women with polycystic ovary syndrome. , 1994, Fertility and sterility.

[28]  S. Ojeda,et al.  Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. , 1993, Endocrinology.

[29]  S. Ojeda,et al.  Activation of ovarian sympathetic nerves in polycystic ovary syndrome. , 1993, Endocrinology.

[30]  S. Johansson,et al.  Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women , 1992, Acta obstetricia et gynecologica Scandinavica.

[31]  D. Finegood,et al.  Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. , 1992, The Journal of clinical endocrinology and metabolism.

[32]  P. Björntorp,et al.  Effects of testosterone on muscle insulin sensitivity and morphology in female rats. , 1990, The American journal of physiology.

[33]  P. Mauvais-Jarvis,et al.  Pathophysiology of polycystic ovary syndrome. , 1989, Journal of steroid biochemistry.

[34]  J. Brawer,et al.  Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. , 1986, Biology of reproduction.

[35]  R. Racotta,et al.  Metabolic effects of chronic infusions of epinephrine and norepinephrine in rats. , 1986, The American journal of physiology.

[36]  D. Mishell,et al.  Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. , 1983, American journal of obstetrics and gynecology.

[37]  R. Lahti,et al.  The effect of minor tranquilizers on stress-induced increases in rat plasma corticosteroids , 1974, Psychopharmacologia.

[38]  S. Bornstein,et al.  Basic and clinical aspects of intraadrenal regulation of steroidogenesis , 2000, Zeitschrift für Rheumatologie.

[39]  J. Uilenbroek,et al.  Polycystic ovary syndrome--searching for an animal model. , 1998, Journal of medicine.

[40]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[41]  I. Semenova.  [Adrenergic innervation of ovaries in Stein-Leventhal syndrome]. , 1969, Vestnik Akademii meditsinskikh nauk SSSR.

[42]  M. Costa,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Intraovarian Excess of Nerve Growth Factor Increases Androgen Secretion and Disrupts Estrous Cyclicity in the Rat* , 2022 .